Dianthus Therapeutics Financial Overview
Dianthus Therapeutics's market cap is currently $1.32B. The company's EPS TTM is $-0.97; its P/E ratio is -10.20; Dianthus Therapeutics is scheduled to report earnings on November 5, 2025, and the estimated EPS forecast is $-1.07. See an overview of income statement, balance sheet, and cash flow financials.
